Teva Pharmaceutical Industries Ltd (TEVJF) Restructuring Costs (2009 - 2013)
Teva Pharmaceutical Industries' (TEVJF) quarterly Restructuring Costs came in at $47.0 million in Q3 2013, down 93.18% YoY from $689.0 million in Q3 2012, and down 96.72% on a QoQ basis from $1.4 billion in Q2 2013.
Teva Pharmaceutical Industries Ltd (TEVJF) Restructuring Costs (2009 - 2013) Analysis & Trends
Teva Pharmaceutical Industries (TEVJF) has 4 years of Restructuring Costs data on file, last reported at $47.0 million in Q3 2013.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 47.00 Mn |
| Jun 30, 2013 | 1.44 Bn |
| Mar 31, 2013 | 41.00 Mn |
| Sep 30, 2012 | 689.00 Mn |
| Jun 30, 2012 | 21.00 Mn |
| Mar 31, 2012 | 40.00 Mn |
| Sep 30, 2011 | 36.00 Mn |
| Sep 30, 2009 | 97.00 Mn |
| Jun 30, 2009 | 52.00 Mn |
| Mar 31, 2009 | 14.00 Mn |